Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed With Plasmodium Falciparum

Condition:   Malaria Intervention:   Drug: Meplazumab for Injection Sponsor:   Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd Not yet recruiting

Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials